Myriad Genetics, Inc. Share Price
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
01:03:08 18/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 4.100 USD | +6.22% |
|
+23.96% | -32.28% |
| 16/09 | Myriad Genetics, Inc. Announces Management Changes | CI |
| 09/09 | UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating | MT |
| Market Cap | 37Cr 32Cr 30Cr 28Cr 52Cr 3.54TCr 52Cr 362.51Cr 140.17Cr 1.8TCr 138.7Cr 135.61Cr 5.75TCr | P/E 2026 * |
-2.43x | P/E 2027 * | -3.08x |
|---|---|---|---|---|---|
| Enterprise Value | 32Cr 28Cr 26Cr 24Cr 45Cr 3.07TCr 45Cr 314.4Cr 121.57Cr 1.56TCr 120.29Cr 117.61Cr 4.99TCr | EV / Sales 2026 * |
0.41x | EV / Sales 2027 * | 0.36x |
| Free-Float |
96.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MYGN | Delayed | |
CBOE
| MYGN | Real-time | |
|
Boerse Muenchen
| MYD | Real-time | |
|
Deutsche Boerse AG
| MYD | Delayed | |
|
Tradegate
| MYD | Real-time | |
|
Börse Stuttgart
| MYD | Delayed |
Last Transcript: Myriad Genetics, Inc.
| 1 day | +6.22% | ||
| 1 week | +23.96% | ||
| Current month | +29.35% | ||
| 1 month | +36.56% | ||
| 3 months | -4.91% | ||
| 6 months | -12.87% | ||
| Current year | -32.28% |
| 1 week | 3.2 |  | 4.17 |
| 1 month | 2.84 | | 4.17 |
| Current year | 2.74 | | 7.15 |
| 1 year | 2.74 | | 8.59 |
| 3 years | 2.74 | | 29.3 |
| 5 years | 2.74 | | 35.31 |
| 10 years | 2.74 | | 50.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samraat Raha
CEO | Chief Executive Officer | 54 | 30/04/2025 |
Benjamin Wheeler
DFI | Director of Finance/CFO | 43 | 16/08/2025 |
Raj Jampa
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
S. Phanstiel
CHM | Chairman | 67 | 23/03/2020 |
Heiner Dreismann
BRD | Director/Board Member | 71 | 10/06/2010 |
Colleen Reitan
BRD | Director/Board Member | 66 | 25/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Tax | General Counsel | -4,398 | 0.0046% | ||
| 16/08/26 | Tax | Chief Financial Officer | -8,761 | 0.0093% | ||
| 11/06/26 | Free | Chief Executive Officer | 3,542 | 0.0038% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.22% | +23.96% | -43.72% | -75.54% | 37Cr | |
| +3.77% | +14.81% | +219.27% | +542.02% | 2.35TCr | |
| -0.48% | +0.70% | -36.53% | -21.12% | 983.94Cr | |
| +6.34% | +17.66% | +507.31% | +69.08% | 946.96Cr | |
| +10.30% | +29.64% | -7.05% | - | 797.2Cr | |
| +0.37% | +0.47% | +98.40% | +57.36% | 656.25Cr | |
| +0.22% | -0.12% | -28.75% | -24.49% | 573.64Cr | |
| +1.30% | +3.61% | -3.12% | -16.16% | 429.99Cr | |
| +0.95% | -7.49% | +54.90% | +64.65% | 374.3Cr | |
| +0.78% | +0.31% | -21.64% | -30.67% | 271.85Cr | |
| Average | +2.99% | +6.00% | +73.91% | +62.79% | 741.81Cr | |
| Weighted average by Cap. | +3.31% | +5.76% | +136.59% | +203.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78Cr 68Cr 64Cr 58Cr 108.83Cr 7.45TCr 109.37Cr 763.71Cr 295.31Cr 3.79TCr 292.19Cr 285.69Cr 12TCr | 82Cr 72Cr 68Cr 62Cr 114.9Cr 7.86TCr 115.46Cr 806.27Cr 311.76Cr 4TCr 308.48Cr 301.61Cr 13TCr |
| Net income | -14Cr -12Cr -12Cr -11Cr -20Cr -1.37TCr -20Cr -140.73Cr -54Cr -697.61Cr -54Cr -53Cr -2.23TCr | -11Cr -9.24Cr -8.75Cr -7.95Cr -15Cr -1.02TCr -15Cr -104.19Cr -40Cr -516.49Cr -40Cr -39Cr -1.65TCr |
| Net Debt | -4.9Cr -4.27Cr -4.04Cr -3.67Cr -6.86Cr -469.25Cr -6.89Cr -48Cr -19Cr -238.48Cr -18Cr -18Cr -763.42Cr | -7.41Cr -6.46Cr -6.11Cr -5.55Cr -10Cr -710.04Cr -10Cr -73Cr -28Cr -360.85Cr -28Cr -27Cr -1.16TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $4.155 | +7.64% | 18,92,230 |
| 16/26/16 | $3.860 | -0.52% | 20,49,663 |
| 15/26/15 | $3.880 | +2.37% | 46,80,388 |
| 14/26/14 | $3.790 | +10.82% | 25,99,405 |
| 11/26/11 | $3.420 | +1.79% | 25,52,959 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MYGN Stock
Select your edition
All financial news and data tailored to specific country editions
